Literature DB >> 10329730

The interaction between the forkhead thyroid transcription factor TTF-2 and the constitutive factor CTF/NF-1 is required for efficient hormonal regulation of the thyroperoxidase gene transcription.

L Ortiz1, P Aza-Blanc, M Zannini, A C Cato, P Santisteban.   

Abstract

The forkhead thyroid-specific transcription factor TTF-2 is the main mediator of thyrotropin and insulin regulation of thyroperoxidase (TPO) gene expression. This function depends on multimerization and specific orientation of its DNA-binding site, suggesting that TTF-2 is part of a complex interaction network within the TPO promoter. This was confirmed by transfection experiments and by protein-DNA interaction studies, which demonstrated that CTF/NF1 proteins bind 10 base pairs upstream of the TTF-2-binding site to enhance its action in hormone-induced expression of the TPO gene. GST pull-down assays showed that TTF-2 physically interacts with CTF/NF1 proteins. In addition, we demonstrate that increasing the distance between both transcription factors binding sites by base pair insertion results in loss of promoter activity and in a drastic decrease on the ability of the promoter to respond to the hormones. CTF/NF1 is a family of transcription factors that contributes to constitutive and cell-type specific gene expression. Originally identified as factors implicated in the replication of adenovirus, this group of proteins (CTF/NF1-A, -B, -C, and -X) is now known to be involved in the regulation of several genes. In contrast to other reports regarding the involvement of these proteins in inducible gene expression, we show here that members of this family of transcription factors are regulated by hormones. With the use of specific CTF/NF1 DNA probes and antibodies we demonstrate that CTF/NF1-C is a thyrotropin-, cAMP-, and insulin-inducible protein. Thus CTF/NF1 proteins do not only mediate hormone-induced gene expression cooperating with TTF-2, but are themselves hormonally regulated. All these findings are clearly of important value in understanding the mechanisms governing the transcription regulation of RNA polymerase II promoters, which often contain binding sites for multiple transcription factors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329730     DOI: 10.1074/jbc.274.21.15213

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis.

Authors:  Matthew J Simmonds
Journal:  Nat Rev Endocrinol       Date:  2013-03-26       Impact factor: 43.330

2.  Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies.

Authors:  Joshua C Denny; Dana C Crawford; Marylyn D Ritchie; Suzette J Bielinski; Melissa A Basford; Yuki Bradford; High Seng Chai; Lisa Bastarache; Rebecca Zuvich; Peggy Peissig; David Carrell; Andrea H Ramirez; Jyotishman Pathak; Russell A Wilke; Luke Rasmussen; Xiaoming Wang; Jennifer A Pacheco; Abel N Kho; M Geoffrey Hayes; Noah Weston; Martha Matsumoto; Peter A Kopp; Katherine M Newton; Gail P Jarvik; Rongling Li; Teri A Manolio; Iftikhar J Kullo; Christopher G Chute; Rex L Chisholm; Eric B Larson; Catherine A McCarty; Daniel R Masys; Dan M Roden; Mariza de Andrade
Journal:  Am J Hum Genet       Date:  2011-10-07       Impact factor: 11.025

3.  Prodos is a conserved transcriptional regulator that interacts with dTAF(II)16 in Drosophila melanogaster.

Authors:  A Hernández-Hernández; A Ferrús
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

Review 4.  Thyroid transcription factors in development, differentiation and disease.

Authors:  Lara P Fernández; Arístides López-Márquez; Pilar Santisteban
Journal:  Nat Rev Endocrinol       Date:  2014-10-28       Impact factor: 43.330

5.  The forkhead factor FoxE1 binds to the thyroperoxidase promoter during thyroid cell differentiation and modifies compacted chromatin structure.

Authors:  Isabel Cuesta; Kenneth S Zaret; Pilar Santisteban
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

6.  The CAAT-binding transcription factor 1/nuclear factor 1 binding site is important in beta-myosin heavy chain antisense promoter regulation in rats.

Authors:  Julia M Giger; Paul W Bodell; Kenneth M Baldwin; Fadia Haddad
Journal:  Exp Physiol       Date:  2009-08-14       Impact factor: 2.969

7.  Nuclear factor I/thyroid transcription factor 1 interactions modulate surfactant protein C transcription.

Authors:  Cindy J Bachurski; Guan Hu Yang; Tracey A Currier; Richard M Gronostajski; Dihua Hong
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

8.  nfi-I affects behavior and life-span in C. elegans but is not essential for DNA replication or survival.

Authors:  Elena Lazakovitch; John M Kalb; Reiko Matsumoto; Keiko Hirono; Yuji Kohara; Richard M Gronostajski
Journal:  BMC Dev Biol       Date:  2005-10-20       Impact factor: 1.978

9.  New insights into FoxE1 functions: identification of direct FoxE1 targets in thyroid cells.

Authors:  Lara P Fernández; Arístides López-Márquez; Angel M Martínez; Gonzalo Gómez-López; Pilar Santisteban
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

10.  Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease.

Authors:  Marco Medici; Eleonora Porcu; Giorgio Pistis; Alexander Teumer; Suzanne J Brown; Richard A Jensen; Rajesh Rawal; Greet L Roef; Theo S Plantinga; Sita H Vermeulen; Jari Lahti; Matthew J Simmonds; Lise Lotte N Husemoen; Rachel M Freathy; Beverley M Shields; Diana Pietzner; Rebecca Nagy; Linda Broer; Layal Chaker; Tim I M Korevaar; Maria Grazia Plia; Cinzia Sala; Uwe Völker; J Brent Richards; Fred C Sweep; Christian Gieger; Tanguy Corre; Eero Kajantie; Betina Thuesen; Youri E Taes; W Edward Visser; Andrew T Hattersley; Jürgen Kratzsch; Alexander Hamilton; Wei Li; Georg Homuth; Monia Lobina; Stefano Mariotti; Nicole Soranzo; Massimiliano Cocca; Matthias Nauck; Christin Spielhagen; Alec Ross; Alice Arnold; Martijn van de Bunt; Sandya Liyanarachchi; Margit Heier; Hans Jörgen Grabe; Corrado Masciullo; Tessel E Galesloot; Ee M Lim; Eva Reischl; Peter J Leedman; Sandra Lai; Alessandro Delitala; Alexandra P Bremner; David I W Philips; John P Beilby; Antonella Mulas; Matteo Vocale; Goncalo Abecasis; Tom Forsen; Alan James; Elisabeth Widen; Jennie Hui; Holger Prokisch; Ernst E Rietzschel; Aarno Palotie; Peter Feddema; Stephen J Fletcher; Katharina Schramm; Jerome I Rotter; Alexander Kluttig; Dörte Radke; Michela Traglia; Gabriela L Surdulescu; Huiling He; Jayne A Franklyn; Daniel Tiller; Bijay Vaidya; Tim de Meyer; Torben Jørgensen; Johan G Eriksson; Peter C O'Leary; Eric Wichmann; Ad R Hermus; Bruce M Psaty; Till Ittermann; Albert Hofman; Emanuele Bosi; David Schlessinger; Henri Wallaschofski; Nicola Pirastu; Yurii S Aulchenko; Albert de la Chapelle; Romana T Netea-Maier; Stephen C L Gough; Henriette Meyer Zu Schwabedissen; Timothy M Frayling; Jean-Marc Kaufman; Allan Linneberg; Katri Räikkönen; Johannes W A Smit; Lambertus A Kiemeney; Fernando Rivadeneira; André G Uitterlinden; John P Walsh; Christa Meisinger; Martin den Heijer; Theo J Visser; Timothy D Spector; Scott G Wilson; Henry Völzke; Anne Cappola; Daniela Toniolo; Serena Sanna; Silvia Naitza; Robin P Peeters
Journal:  PLoS Genet       Date:  2014-02-27       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.